Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Users online: 56  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
Year : 2010  |  Volume : 55  |  Issue : 2  |  Page : 171-175

Targeting IL-23: Insights into the pathogenesis and the treatment of psoriasis

1 Department of Medical Pathology, Federal University of Parana - Curitiba, PR - Brazil,
2 Department of Dermatology, Clinical Unit for Research Trials in Skin - Massachusetts General Hospital, Harvard Medical School - Boston, MA - USA,

Correspondence Address:
Hermenio Cavalcante Lima
Associate Professor, Division of Dermatology, Department of Medicine. 1200 Main St. W. Hamilton Ontario L8N 3Z5, Canada

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-5154.62760

Get Permissions

Therapeutic experience strongly supports the use of TNF antagonists as important modalities in the treatment of psoriatic arthritis and plaque psoriasis. Studies with anti-IL-12/23 therapeutic agents, which act in different steps of the psoriatic inflammatory cascade, have also shown demonstrable efficacy. Here, we discuss this approach and its potential within the armamentarium for the treatment of psoriasis. Evidences that the selective blocking of IL-23 may be effective and safe therapy are also addressed.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded288    
    Comments [Add]    
    Cited by others 4    

Recommend this journal


Site supported by Galderma